Phase I/II trial of IMO 2055 in patients with solid tumours
Phase of Trial: Phase I/II
Latest Information Update: 05 Mar 2008
At a glance
- Drugs Carboplatin; Gemcitabine; IMO 2055
- Indications Solid tumours
- Focus Adverse reactions
- 05 Mar 2008 Status change from in progress to completed, according to an Idera Pharmaceuticals media release.
- 13 Sep 2007 New trial record.